Stock Events

Stock Events

Certara 

$8.41
31
+$0.00+0% 12:55 Today

Statistics

Day High
8.42
Day Low
8.4
52W High
13.88
52W Low
4.45
Volume
71,457
Avg. Volume
-
Mkt Cap
1.28B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.07
0.1
0.12
0.15
Expected EPS
0.088867
Actual EPS
N/A

Financials

-0.38%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
418.84MRevenue
-1.6MNet Income

Analyst Ratings

7.79Average Price Target
The highest estimate is 10.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
29%
Hold
71%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CERT. It's not an investment recommendation.
Tesla
10
TSLA
NVIDIA
10
NVDA
Microsoft
8
MSFT
Amazon
7
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Summit Therapeutics
SMMT
Mkt Cap10.5B
Summit Therapeutics competes in the biopharmaceutical sector, offering data analytics and simulation services similar to Certara's, focusing on drug discovery and development.
PDS Biotechnology
PDSB
Mkt Cap12.23M
PDS Biotechnology operates in the biotech field, providing solutions that overlap with Certara's offerings in pharmacokinetics and pharmacodynamics modeling for drug development.
Evelo Biosciences
EVLO
Mkt Cap1,898
Evelo Biosciences, engaged in the biotech industry, offers competitive solutions in drug discovery and development, areas where Certara also operates.
Phreesia
PHR
Mkt Cap749.16M
Phreesia provides healthcare software solutions that, while more focused on patient management, indirectly competes with Certara's data analytics for clinical trials.
Medpace
MEDP
Mkt Cap17.33B
Medpace Holdings offers clinical research services that compete with Certara in the drug development process, particularly in clinical trial management and data analysis.
Charles River Laboratories International
CRL
Mkt Cap14.09B
Charles River Laboratories provides a range of preclinical and clinical laboratory services that compete with Certara in drug development and regulatory support.
IQVIA
IQV
Mkt Cap42.77B
IQVIA offers extensive clinical research and analytics services, making it a direct competitor to Certara in the pharmaceutical and healthcare data analytics market.

About

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Show more...
CEO
Jon Resnick
Employees
1576
Country
United States
ISIN
US15687V1098

Listings

MX
MX
CERT.MX
XNAS
US
CERT
BOATS
BOATS
CERT.BOATS

0 Comments

Share your thoughts

FAQ

What is Certara stock price today?▼
The current price of CERT is $8.41 USD — it has increased by +0% in the past 24 hours. Watch Certara stock price performance more closely on the chart.
What is Certara stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Certara stocks are traded under the ticker CERT.
Is Certara stock price growing?▼
CERT stock has fallen by -0.24% compared to the previous week, the month change is a +6.32% rise, over the last year Certara has showed a -22.63% decrease.
What is Certara market cap?▼
Today Certara has the market capitalization of 1.28B
When is the next Certara earnings date?▼
Certara is going to release the next earnings report on November 11, 2026.
What were Certara earnings last quarter?▼
CERT earnings for the last quarter are 0.08 USD per share, whereas the estimation was 0.09 USD resulting in a -10.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Certara revenue for the last year?▼
Certara revenue for the last year amounts to 418.84M USD.
What is Certara net income for the last year?▼
CERT net income for the last year is -1.6M USD.
How many employees does Certara have?▼
As of August 28, 2026, the company has 1,576 employees.
In which sector is Certara located?▼
Certara operates in the Health & Wellness sector.
When did Certara complete a stock split?▼
The last stock split for Certara was on July 13, 2000 with a ratio of 2:1.
Where is Certara headquartered?▼
Certara is headquartered in RADNOR, United States.